Skip to main navigation
Skip to search
Skip to main content
Universitas Indonesia Home
Home
Profiles
Research units
Research output
Equipments
Projects
Activities
Press/Media
Search by expertise, name or affiliation
View Scopus Profile
Yusra
Faculty of Medicine
,
Department of Clinical Pathology
h-index
36
Citations
2
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2012
2023
Research activity per year
Overview
Fingerprint
Network
Projects
(7)
Research output
(43)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Yusra is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Depok
100%
Pandemi
100%
COVID-19
100%
Webinar
100%
Hospital Preparedness
100%
Pre-diabetes (pre-DM)
50%
Pada
35%
Lipid Profile
21%
Iron Markers
16%
HbA1c Levels
16%
Cyclooxygenase-2
16%
Fecal Immunochemical Test
16%
Invasive Front
16%
Alkaline Phosphatase
16%
Transferases
16%
Liver
16%
Index Score
16%
Colorectal Cancer
16%
Colorectal Cancer Cells
16%
Glucagon-like
16%
Sambiloto
16%
Uterus
16%
Andrographis Paniculata
16%
Bilirubin
16%
Aspartate Aminotransferase-to-platelet Ratio Index
16%
LDL Cholesterol
16%
Biological Significance
16%
Serum Lipids
16%
Analisis
16%
Dipeptidyl peptidase-4 (DPP-4)
16%
Hemodialysis Patients
16%
Synthetic Function
16%
CD133
16%
Cirrhotic Patients
16%
Tumor Budding
16%
Transferrin Receptor 1 (TfR1)
16%
Liver Cirrhosis
16%
Hyperimmunoglobulin E Syndrome
16%
AST-to-platelet Ratio Index
13%
Cholesterol
12%
Cirrhosis
11%
PD-related Peritonitis
11%
Gamma-glutamyltransferase
11%
SW480 Cells
9%
Albumin
9%
Colorectal Carcinoma
9%
Triglycerides
8%
Audio
8%
SNAI1
7%
Transforming Growth Factor-β
7%
Medicine and Dentistry
Liver Cirrhosis
33%
Impaired Glucose Tolerance
23%
Gelatinase A
19%
Glucagon Like Peptide 1
16%
Colorectal Carcinoma
16%
Serum Albumin
16%
Carcinoma Cell
16%
Cyclooxygenase 2
16%
Occult Blood Test
16%
Neoplasm
16%
Protein P53
16%
Gelatinase B
16%
Metalloprotease Inhibitor
16%
Aspartate Aminotransferase
16%
Peritonitis
16%
Transferase
16%
Peritoneal Dialysis
16%
Bilirubin
16%
Andrographis paniculata
16%
Alkaline Phosphatase
16%
Adenosine Deaminase
16%
Colorectal Cancer
16%
Erythrocyte Sedimentation Rate
16%
Leukocyte
16%
Cell Count
16%
Gastrointestinal Tuberculosis
16%
Peritoneal Fluid
16%
Platelet
16%
Dipeptidyl Peptidase IV
16%
High Density Lipoprotein Cholesterol
13%
Blood Glucose
13%
Triacylglycerol
10%
Low Density Lipoprotein Cholesterol
10%
Placebo
10%
Gamma-Glutamyl Transpeptidase
9%
Transforming Growth Factor
8%
Medical Record
7%
Glycosylated Albumin
6%
Heart Disease
6%
Homeostatic Model Assessment
6%
Diagnostic Accuracy
6%
Fibrosis
5%
Liver Function
5%
Carcinogenicity
5%
Mesenchymal-Epithelial Transition
5%
Pharmacology, Toxicology and Pharmaceutical Science
Midazolam
100%
Peritonitis
16%
Gelatinase A
16%
Aspartate Aminotransferase
16%
Alkaline Phosphatase
16%
Cyclooxygenase 2
16%
Tissue Inhibitor of Metalloproteinase
16%
Glucagon-Like Peptide-1
16%
Hemodialysis
16%
Protein P53
16%
Colorectal Cancer
16%
Gelatinase B
16%
Bilirubin
16%
Andrographis paniculata
16%
Dipeptidyl Peptidase IV
16%
Liver Cirrhosis
16%
Transferase
16%
Transferrin Receptor
16%
Gamma Glutamyltransferase
13%
Placebo
10%
Cross-Sectional Study
7%
Iron Deficiency
6%
End Stage Renal Disease
6%
Impaired Glucose Tolerance
6%
Insulin Resistance
6%
Glycosylated Albumin
6%
Transferrin
5%
